图 书 馆开课单位--蒙得维的亚巴斯德学院
1 1/1
1Masitinib for the treatment of amyotrophic lateral sclerosis (ALS): preclinical overview[马西替尼治疗肌萎缩侧索硬化症（ALS）：临床前概述]
Luis Barbeito(蒙得维的亚巴斯德学院) Masitinib is a selective oral tyrosine kinase inhibitor targeting CSF1R and c-Kit. Clinical data from the phase 3 study (AB10015) of masitinib in amyo...
热度：277
Luis Barbeito(蒙得维的亚巴斯德学院) Masitinib is a selective oral tyrosine kinase inhibitor targeting CSF1R and c-Kit. Clinical data from the phase 3 study (AB10015) of masitinib in amyo...
热度：277
1 1/1